New Treatments for Acromegaly in Development-Reference-Cited by-同舟云学术

New Treatments for Acromegaly in Development

Published:2023-09-27 Issue: Volume: Page:
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Gadelha Mônica R¹²³^ORCID,Gadelha Ana Carolina¹,Kasuki Leandro¹²

Affiliation:

1. Endocrine Unit and Neuroendocrinology Research Center, Medical School and Hospital Universitário Clementino Fraga Filho—Universidade Federal do Rio de Janeiro , Rio de Janeiro 21941-913 , Brazil

2. Neuroendocrine Unit—Instituto Estadual do Cérebro Paulo Niemeyer, Secretaria Estadual de Saúde , Rio de Janeiro 20231-092 , Brazil

3. Neuropathology and Molecular Genetics Laboratory, Instituto Estadual do Cérebro Paulo Niemeyer, Secretaria Estadual de Saúde , Rio de Janeiro 20231-092 , Brazil

Abstract

Abstract Acromegaly treatment has greatly evolved in recent decades, but there are still patients whose acromegaly is not controlled with currently available treatments, and there is a need to improve the treatment burden. Fortunately, there are new treatments under development that may increase treatment efficacy and convenience.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

https://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgad568/52031321/dgad568.pdf

Reference33 articles.

1. Systemic complications of acromegaly and the impact of the current treatment landscape: an update;Gadelha;Endocr Rev,2019

2. Multidisciplinary management of acromegaly: a consensus;Giustina;Rev Endocr Metab Disord,2020

3. National acromegaly registries;Maione;Best Pract Res Clin Endocrinol Metab,2019

4. Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice;Geer;BMC Endocr Disord,2020

5. Acrobat edge: safety and efficacy of switching injected SRLs to oral paltusotine in patients with acromegaly;Gadelha;J Clin Endocrinol Metab,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure and Function of Somatostatin and Its Receptors in Endocrinology;Endocrine Reviews;2024-08-08

2. Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07